Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: GENERAL BIOLOGICS INC
Awarding agency: Department of Defense / Defense Advanced Research Projects Agency
Funding agency: Department of Defense / Defense Advanced Research Projects Agency
Period of performance: 2021-06-15 to 2023-07-01
Current total value of award: $500000
Description: DESCOPE MODIFICATION TO PHASE II STTR UNDER PROGRAM PATTERNED RESPONSIVE CELLULAR THERAPIES USING NOVEL MAMMALIAN CELLULAR REGULATOR SYSTEM PROGRAM